pd 98059 has been researched along with Altitude Hypoxia in 2 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Altitude Hypoxia: Low ambient oxygen tension associated with ALTITUDE.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Han, YF | 2 |
Ji, LH | 2 |
Feng, TT | 2 |
Liu, F | 2 |
Cui, S | 2 |
Su, J | 2 |
Ren, R | 1 |
Li, JP | 1 |
Luo, W | 1 |
2 other studies available for pd 98059 and Altitude Hypoxia
Article | Year |
---|---|
[Effect of ERK1/2 Signaling Pathway Inhibitor PD98059 on the Expression of Ras, BRaf, MEK, ERK1/2 in Marrow Nucleated Red Blood Cells of CMS Patients].
Topics: Altitude Sickness; Bone Marrow; Flavonoids; Humans; Mitogen-Activated Protein Kinase 3; Proto-Oncoge | 2017 |
[Effect of PD98059 on Proliferation and Apoptosis of CD71(+),CD235a(+) Nucleated Erythrocytes in the Patients with High Altitude Polycythemia].
Topics: Altitude Sickness; Apoptosis; Bone Marrow; Bone Marrow Cells; Cell Proliferation; Erythroblasts; Ery | 2016 |